Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acme United | ACU | May 31, 2024 | 35.49 | +0.37 |
ACNB | ACNB | May 31, 2024 | 31.57 | -1.25 |
ACRES Commercial Realty | ACR | May 31, 2024 | 12.41 | -0.48 |
ACRES Commercial Realty C Pref | ACR-C | May 31, 2024 | 24.74 | +0.37 |
ACRES Commercial Realty D Pref | ACR-D | May 31, 2024 | 20.69 | -0.14 |
Acrivon Therapeutics | ACRV | May 31, 2024 | 7.72 | +1.98 |
Actelis Networks | ASNS | May 31, 2024 | 0.44 | -10.00 |
Actinium Pharmaceuticals | ATNM | May 31, 2024 | 8.15 | +0.49 |
Active Bear ETF | HDGE | May 31, 2024 | 20.67 | -0.48 |
Active U.S. Real Estate Powershares | PSR | May 31, 2024 | 85.29 | +2.19 |
Acuity Brands | AYI | May 31, 2024 | 259.61 | +1.02 |
Acumen Pharmaceuticals | ABOS | May 31, 2024 | 2.94 | -1.34 |
Acurx Pharmaceuticals | ACXP | May 31, 2024 | 2.51 | 0.00 |
Acushnet | GOLF | May 31, 2024 | 65.90 | +1.89 |
Acutus Medical | AFIB | May 31, 2024 | 0.12 | 0.00 |
ACV Auctions A | ACVA | May 31, 2024 | 17.85 | -1.16 |
ACWI Ex-US Index MSCI Ishares | ACWX | May 31, 2024 | 54.15 | +0.39 |
ACWI Index MSCI Ishares | ACWI | May 31, 2024 | 111.08 | +0.69 |
Adagene ADR | ADAG | May 31, 2024 | 2.80 | +7.90 |
Adamas One | JEWL | May 31, 2024 | 0.41 | +15.97 |
Adams Diversified Equity Fund | ADX | May 31, 2024 | 20.44 | +1.74 |
Adams Natural Resources Fund | PEO | May 31, 2024 | 23.64 | +1.98 |
Adams Resources & Energy | AE | May 31, 2024 | 26.46 | +2.24 |
AdaptHealth | AHCO | May 31, 2024 | 9.48 | -2.17 |
Adaptimmune Therapeutics ADR | ADAP | May 31, 2024 | 1.13 | +11.88 |
Adaptive Biotechnologies | ADPT | May 31, 2024 | 3.45 | -4.43 |
ADC Therapeutics SA | ADCT | May 31, 2024 | 3.43 | -0.29 |
Addentax Group | ATXG | May 31, 2024 | 1.01 | -0.49 |
Addex Therapeutics ADR | ADXN | May 31, 2024 | 8.60 | -0.46 |
Addus HomeCare | ADUS | May 31, 2024 | 114.81 | +2.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.